Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block

NCT ID: NCT06899841

Last Updated: 2025-03-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE2/PHASE3

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-01

Study Completion Date

2026-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to investigate the postoperative analgesic effect of dexmedetomidine addition with different doses as an adjuvant to bupivacaine to Erector spinae plane block after renal surgeries.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

low dose dex

0.5 mic/kg of dexmedetomidine administered

Group Type EXPERIMENTAL

Dexmedetomidine

Intervention Type DRUG

different doses of dexmedetomidine added to bupivacaine in erector spinae plane block

intermediate dose dex

0.75 mic/kg of dexmedetomidine administered

Group Type EXPERIMENTAL

Dexmedetomidine

Intervention Type DRUG

different doses of dexmedetomidine added to bupivacaine in erector spinae plane block

high dose dex

1 mic/kg of dexmedetomidine administered

Group Type EXPERIMENTAL

Dexmedetomidine

Intervention Type DRUG

different doses of dexmedetomidine added to bupivacaine in erector spinae plane block

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dexmedetomidine

different doses of dexmedetomidine added to bupivacaine in erector spinae plane block

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 and 70 years.
* Both sexes, males and females.
* Patients with the American Society of Anesthesiologists (ASA) physical status I/II.
* Body mass index (BMI) of 18-35 kg/m2
* Patients scheduled for elective Renal or Percutaneous Nephrolithotomy.

Exclusion Criteria

* Patients under 18 years.
* Patient refusal of nerve block.
* Infection at the site of injection.
* Coagulopathy.
* Allergy to used medications.
* Psychiatric disorder or chronic pain syndromes.
* Chronic opioid use or substance abuse.
* Quadriplegic patients.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahmoud Faisal

dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut University Hospitals

Asyut, Assiut Governorate, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mahmoud Adel Faisal, lecturer

Role: primary

01004391577

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

04-2024-200943

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dexmedetomidine in Postoperative Analgesia
NCT05705128 ENROLLING_BY_INVITATION PHASE2/PHASE3
Dexmedetomidine in IVRA
NCT05123170 COMPLETED PHASE4